|
|
OutsourcingThe CRO market size is estimated at $10 Billion and growing. CROs provide product development services to the pharmaceutical and biotechnology industries, allowing their clients to manage product-development efforts more efficiently and cost-effectively. There is a demand for CRO professionals to bring their scientific, regulatory and information management expertise to bear for the completion of timely, accurate, cost-effective trials. By outsourcing, sponsors gain the benefits of CRO experience, even while controlling costs and reducing the research and development timeline. The growing trend in outsourcing includes the purchasing of products as well as services and ranges from manufacturing through to IT and logistics. Inevitable signs of globalization simply cannot be overlooked in the face of competition:oof-shore and near shore partners allow executives to align their enterprise and culture with consumer demand in the global market. Outsourcing their non-core processes allows pharmaceutical companies to concentrate on their core processes, which strengthens their operations, increasing market presence and shareholders’ value. R&D capabilities: A value-added feature in
a central laboratory The right direction in outsourcing Leading lights in the fight against cancer Strategic outsourcing: the viable option Shaping third party production A new approach to outsourced pharmaceutical manufacturing |
Article Article Article Article Article Article |